| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |